Harbour Investments’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48 Hold
35
﹤0.01% 4676
2026
Q1
$32 Buy
+35
New +$37 ﹤0.01% 4601
2025
Q3
Sell
-25
Closed -$35 3819
2025
Q2
$35 Hold
25
﹤0.01% 3563
2025
Q1
$29 Hold
25
﹤0.01% 3513
2024
Q4
$36 Hold
25
﹤0.01% 3448
2024
Q3
$38 Hold
25
﹤0.01% 3355
2024
Q2
$43 Hold
25
﹤0.01% 3244
2024
Q1
$29 Buy
+25
New +$29 ﹤0.01% 3188
2021
Q4
Sell
-35
Closed 3333
2021
Q3
$0 Hold
35
﹤0.01% 3898
2021
Q2
$0 Hold
35
﹤0.01% 3892
2021
Q1
$0 Buy
+35
New +$158 ﹤0.01% 3678

Other funds holding NNVC

Harbour Investments's NNVC Position: Q2 2026 in Review

Harbour Investments held its NanoViricides (NNVC) position steady in Q2 2026 at 35 shares worth $48. The position accounts for ﹤0.01% of the portfolio, ranked #4676.

Harbour Investments first reported a position in NNVC in Q1 2021 and has held it in 11 quarters since. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • Harbour Investments held 35 shares of NanoViricides worth $48 as of Q2 2026.
  • Harbour Investments left its NanoViricides share count unchanged in Q2 2026.
  • NanoViricides made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4676 holding.
  • Harbour Investments first reported a position in NanoViricides in Q1 2021 and has held it in 11 quarters since.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.